human | Q5 |
P6178 | Dimensions author ID | 0647145701.51 |
P269 | IdRef ID | 083449019 |
P213 | ISNI | 0000000357139663 |
P496 | ORCID iD | 0000-0003-3363-6411 |
P1053 | ResearcherID | H-4261-2018 |
P10861 | Springer Nature person ID | 0647145701.51 |
P214 | VIAF ID | 196049018 |
P184 | doctoral advisor | Jacqueline Clavel | Q30830766 |
P69 | educated at | French National Institute of Health and Medical Research | Q1474517 |
P108 | employer | French National Institute of Health and Medical Research | Q1474517 |
P735 | given name | Florence | Q950780 |
Florence | Q950780 | ||
P106 | occupation | researcher | Q1650915 |
P21 | sex or gender | female | Q6581072 |
Q36016386 | 11q13 is a susceptibility locus for hormone receptor positive breast cancer |
Q35871567 | 19p13.1 is a triple-negative-specific breast cancer susceptibility locus |
Q37192589 | A genome-wide association study to identify genetic susceptibility loci that modify ductal and lobular postmenopausal breast cancer risk associated with menopausal hormone therapy use: a two-stage design with replication |
Q57818346 | Abdominal obesity and prostate cancer risk: epidemiological evidence from the EPICAP study |
Q100426881 | Adiposity and endometrial cancer risk in postmenopausal women: a sequential causal mediation analysis |
Q99545000 | African-specific improvement of a polygenic hazard score for age at diagnosis of prostate cancer |
Q57305944 | Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci |
Q63966080 | Author Correction: Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci |
Q64118820 | Author Correction: Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci |
Q60907509 | Author Correction: Germline variation at 8q24 and prostate cancer risk in men of European ancestry |
Q55466745 | Birth characteristics and childhood malignant central nervous sytem tumors: the ESCALE study (French Society for Childhood Cancer). |
Q37379187 | Birth-related characteristics, congenital malformation, maternal reproductive history and neuroblastoma: the ESCALE study (SFCE). |
Q97436075 | Body mass index trajectories and prostate cancer risk: Results from the EPICAP study |
Q51080101 | Breast cancer risk, nightwork, and circadian clock gene polymorphisms. |
Q58317441 | Breast-feeding, fetal loss and childhood acute leukaemia |
Q43979043 | Childhood acute leukemia, early common infections, and allergy: The ESCALE Study |
Q45407709 | Childhood hematopoietic malignancies and parental use of tobacco and alcohol: the ESCALE study (SFCE). |
Q46801325 | Childhood leukaemia, polymorphisms of metabolism enzyme genes, and interactions with maternal tobacco, coffee and alcohol consumption during pregnancy |
Q38854624 | Circadian Disruption and Prostate Cancer Risk: An Updated Review of Epidemiological Evidences |
Q91145257 | Circadian genes and risk of prostate cancer: Findings from the EPICAP study |
Q96162766 | Circadian genes polymorphisms, night work and prostate cancer risk: findings from the EPICAP study |
Q31082788 | Comparison of 6q25 breast cancer hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC) |
Q57278898 | Correction: Comparison of 6q25 Breast Cancer Hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC) |
Q24676459 | Day care, childhood infections, and risk of neuroblastoma |
Q36623920 | Day-care, early common infections and childhood acute leukaemia: a multicentre French case-control study |
Q35098158 | Epidemiological study of prostate cancer (EPICAP): a population-based case-control study in France |
Q39727322 | Estimation of breast, prostate, and colorectal cancer incidence using a French administrative database (general sample of health insurance beneficiaries). |
Q36720821 | Evidence of gene-environment interactions between common breast cancer susceptibility loci and established environmental risk factors |
Q35064451 | Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation |
Q37001227 | Familial history of cancer and childhood acute leukemia: a French population-based case-control study |
Q58317442 | Family cancer history and risk of childhood acute leukemia (France) |
Q34172056 | Family history of autoimmune thyroid disease and childhood acute leukemia |
Q58317427 | Family history of cancer in children with acute leukemia, Hodgkin's lymphoma or non-Hodgkin's lymphoma: The ESCALE study (SFCE) |
Q55311842 | Fine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies candidate causal variants. |
Q34903062 | Fine-scale mapping of the 5q11.2 breast cancer locus reveals at least three independent risk variants regulating MAP3K1. |
Q37367871 | Fine-scale mapping of the FGFR2 breast cancer risk locus: putative functional variants differentially bind FOXA1 and E2F1. |
Q36742577 | Functional variants at the 11q13 risk locus for breast cancer regulate cyclin D1 expression through long-range enhancers |
Q29417068 | Genetic modifiers of menopausal hormone replacement therapy and breast cancer risk: a genome-wide interaction study |
Q35179897 | Genetic variation at CYP3A is associated with age at menarche and breast cancer risk: a case-control study |
Q36842233 | Genome-wide association analysis identifies three new breast cancer susceptibility loci |
Q52720511 | Genome-wide association study identifies susceptibility loci for B-cell childhood acute lymphoblastic leukemia. |
Q47125417 | Genome-wide association study of classical Hodgkin lymphoma identifies key regulators of disease susceptibility |
Q58611475 | Germline variation at 8q24 and prostate cancer risk in men of European ancestry |
Q36276540 | Height and Breast Cancer Risk: Evidence From Prospective Studies and Mendelian Randomization |
Q36144176 | Household exposure to pesticides and risk of childhood acute leukaemia. |
Q28382915 | Household exposure to pesticides and risk of childhood hematopoietic malignancies: The ESCALE study (SFCE) |
Q35102646 | Identification and characterization of novel associations in the CASP8/ALS2CR12 region on chromosome 2 with breast cancer risk |
Q36086247 | Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus |
Q34038964 | Identification of new genetic susceptibility loci for breast cancer through consideration of gene-environment interactions |
Q63604269 | Incidence of childhood leukaemia and non-Hodgkinʼs lymphoma in France: National Registry of Childhood Leukaemia and Lymphoma, 1990–1999 |
Q35104068 | Inherited variants in the inner centromere protein (INCENP) gene of the chromosomal passenger complex contribute to the susceptibility of ER-negative breast cancer |
Q34898735 | Investigation of gene-environment interactions between 47 newly identified breast cancer susceptibility loci and environmental risk factors |
Q29416989 | Large-scale genotyping identifies 41 new loci associated with breast cancer risk |
Q58317429 | Maternal alcohol and coffee drinking, parental smoking and childhood leukaemia: a French population-based case?control study |
Q58317437 | Maternal coffee and alcohol consumption during pregnancy, parental smoking and risk of childhood acute leukaemia |
Q49722295 | Night shift work and breast cancer: a pooled analysis of population-based case-control studies with complete work history. |
Q39850850 | Night work and breast cancer risk defined by human epidermal growth factor receptor-2 (HER2) and hormone receptor status: A population-based case-control study in France |
Q45346343 | Night work and breast cancer: a population-based case-control study in France (the CECILE study). |
Q57565039 | Night work and prostate cancer risk: results from the EPICAP Study |
Q30374367 | No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer. |
Q42373340 | Nonsteroidal anti-inflammatory drugs (NSAIDs) and prostate cancer risk: results from the EPICAP study. |
Q28584533 | PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS |
Q24651277 | Parental smoking, maternal alcohol, coffee and tea consumption during pregnancy and childhood malignant central nervous system tumours: the ESCALE study (SFCE) |
Q57734278 | Positive association between congenital anomalies and risk of neuroblastoma |
Q36583004 | Prediction of breast cancer risk based on profiling with common genetic variants |
Q88478329 | Prostatitis, other genitourinary infections and prostate cancer risk: Influence of non-steroidal anti-inflammatory drugs? Results from the EPICAP study |
Q55508030 | Publisher Correction: Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation. |
Q114677146 | Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction |
Q43051933 | Two Novel Susceptibility Loci for Prostate Cancer in Men of African Ancestry. |
Q36539428 | Vaccination and the risk of childhood acute leukaemia: the ESCALE study (SFCE). |
Q63604277 | [What do interns in Public Health of Ile-de-France (IDF) do during their internship?] |
Q30830766 | Jacqueline Clavel | doctoral student | P185 |
Search more.